Advertisement

Drug Safety

, Volume 31, Issue 10, pp 885–885 | Cite as

Where Does the Evidence for Guidelines Come From? An Example of Monitoring for the Adverse Renal Effects of ACE Inhibitors

  • J. J. Coleman
  • S. E. McDowell
  • R. E. Ferner
Abstract
  • 22 Downloads

Keywords

Renal Function Current Guideline Relevant Article Original Research Guideline Development 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Thomson R, McElroy H, Sudlow M. Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment. BMJ 1998; 316:509–13PubMedCrossRefGoogle Scholar
  2. 2.
    Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 2000; 160: 685–93PubMedCrossRefGoogle Scholar
  3. 3.
    Giannakakis IA, Haidich AB, Contopoulos-Ioannidis DG, et al. Citation of randomized evidence in support of guidelines of therapeutic and preventive interventions. J Clin Epidemiol 2002; 55:545–55PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2008

Authors and Affiliations

  • J. J. Coleman
    • 1
  • S. E. McDowell
    • 2
  • R. E. Ferner
    • 1
    • 2
  1. 1.Department of Clinical PharmacologyUniversity of BirminghamUK
  2. 2.West Midlands Centre for Adverse Drug ReactionsUK

Personalised recommendations